Differently from EVAR, in the setting of AAA there are known predictors of complications which have been investigated through the years such as serum elastin peptides (SEP) and plasmin–antiplasmin (PAP) complexes, MMP-9, IL-6, C-reactive protein (CRP), antitrypsin and IFN-gamma for AAA size, expansion rate or rupture [12,13,14,15,16]. The gene discussed is ELN; the disease is triple-A syndrome.